Publications for Robert Nadelman robert_nadelman@nymc.edu
Biggs, H. M., Behravesh, C. B., Bradley, K. K., Dahlgren, F. S., Drexler, N. A., Dumler, J. S., . . . Nadelman, R. B. (2016). Diagnosis and management of tickborne rickettsial diseases: Rocky mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States. A practical guide for health professionals. MMWR Recommendations and Reports, 65(2), 1-44. This material can be found here.
Khatchikian, C. E., Nadelman, R. B., Nowakowski, J., Schwartz, I., Levy, M. Z., Brisson, D., & Wormser, G. P. (2015). Public health impact of strain specific immunity to Borrelia burgdorferi. BMC Infectious Diseases, 15, 472. doi:10.1186/s12879-015-1190-7
Nadelman, R. B. (2015). Erythema migrans. Infectious Disease Clinics of North America, 29(2), 211-239. doi:10.1016/j.idc.2015.02.001
Weitzner, E., McKenna, D., Nowakowski, J., Dornbush, R., Nadelman, R. B., Visintainer, P., Schwartz, I., . . . Wormser, G. P. (2015). Long-term assessment of post-treatment symptoms in patients with culture-confirmed early Lyme disease. Clinical Infectious Diseases, 61(12), 1800-1806. doi:10.1093/cid/civ735
Wormser, G. P., Weitzner, E., McKenna, D., Nadelman, R. B., Dornbush, R., Visintainer, P., . . . Nowakowski, J. (2015). Long-term assessment of health-related quality of life in patients with culture-confirmed early Lyme disease. Clinical Infectious Diseases, 61(2), 244-247. doi:10.1093/cid/civ277
Wormser, G. P., Weitzner, E., McKenna, D., Nadelman, R. B., Scavarda, C., & Nowakowski, J. (2015). Long-term assessment of fatigue in patients with culture-confirmed Lyme disease. The American Journal of Medicine, 128(2), 181-184. doi:10.1016/j.amjmed.2014.09.022
Khatchikian, C. E., Nadelman, R. B., Nowakowski, J., Schwartz, I., Wormser, G. P., & Brisson, D. (2014). Evidence for strain-specific immunity in patients treated for early Lyme disease. Infection and Immunity, 82(4), 1408-1413. doi:10.1128/IAI.01451-13
Nadelman, R. B., & Wormser, G. P. (2013). Reinfection versus relapse in Lyme disease. New England Journal of Medicine, 368(11), 1063-1064. doi:10.1056/NEJMc1215615
Wormser, G. P., Aguero-Rosenfeld, M. E., Nowakowski, J., Nadelman, R. B., McKenna, D., Liveris, D., . . . Schwartz, I. (2013). Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early Lyme disease. Journal of Clinical Microbiology, 51(3), 954-958. doi:10.1128/JCM.02929-12
Wormser, G. P., Schriefer, M., Aguero-Rosenfeld, M. E., Levin, A., Steere, A. C., Nadelman, R. B., . . . Nowakowski, J. (2013). Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagnostic Microbiology and Infectious Disease, 75(1), 9-15. doi:10.1016/j.diagmicrobio.2012.09.003
